Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
-
1041
-
1042
-
1043
-
1044
-
1045
-
1046
-
1047
-
1048
-
1049
RFR magnitude as a function of time after stimulus level changes (“transient”) and steady state response magnitude to the same stimulus level.
Published 2018“…<p>Each record presents the mean and SD of a Gabor-filtered envelope (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0201121#pone.0201121.g002" target="_blank">Fig 2</a>) of averaged data from three experiments. …”
-
1050
-
1051
-
1052
-
1053
-
1054
-
1055
-
1056
-
1057
Serum and urinary Klotho, S100A8/A9, and neutrophil gelatinase-associated lipocalin (NGAL) concentrations in acute kidney injury patients.
Published 2016“…<p>(a) Urinary Klotho and urinary Klotho/creatinine (Cr) decreased significantly in pre-renal AKI patients. …”
-
1058
Serum and urinary Klotho, S100A8/A9, and Neutrophil gelatinase-associated lipocalin (NGAL) concentrations in an acute kidney injury model.
Published 2016“…(b) Serum and urinary S100A8/A9 and urinary S100A8/A9/Cr increased significantly in the cisplatin (CDDP) group. …”
-
1059
-
1060
Semiquantitative immunoblotting and immunohistochemistry of the kidney from the acute kidney injury model.
Published 2016“…(b) S100A8/A9 abundance was increased in the CDDP group (220%) versus the control (100%) and VD groups (83%). …”